Navigation Links
Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) July 13, 2014

A Massachusetts couple who have done so much to bring attention to the cancer risks associated with power morcellators ( finally had a chance to tell their story to federal regulators, as they presented poignant testimony on the second day of a U.S. Food & Drug Administration (FDA) advisory panel meeting convened to address the issue, Bernstein Liebhard LLP reports. According to the Rochester Democrat and Chronicle, Dr. Hooman Noorchashm and his wife, Dr. Amy Reed, held back tears as they addressed the FDA’s Obstetrics and Gynecology Devices Panel. Dr. Noorchashm began by presenting a collage featuring photos of women who died, allegedly after they suffered the spread of undetected cancers due to uterine morcellation. *

In addressing the Panel, Dr. Noorchashm also criticized its make-up, asserting that it was packed with gynecological surgeons who are protecting their practice of morcellation. Dr. Reed, who is fighting an aggressive form of uterine sarcoma that was allegedly spread by a power morcellator, reminded the panel of outside experts of their obligation to avoid unsafe and dangerous practices. When Dr. Reed ended her remarks, people assembled in the gallery to observe the meeting responded with a standing ovation, according to the Democrat and Chronicle.

“It’s highly doubtful that this meeting would have ever been convened had it not been for the work of Dr. Noorchashm and Dr. Reed. Our Firm is pleased that they, as well as other alleged victims of uterine morcellation, were finally able to tell their stories directly to the FDA,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating morcellator lawsuits on behalf of women who may have experienced the spread of undiagnosed uterine sarcoma and other cancers due to uterine morcellation.

Power Morcellators and Cancer
According to a report from CBS News in Boston, Drs. Noorschasm and Reed have been leading efforts to ban uterine morcellation since Dr. Reed’s cancer diagnosis last year.** A petition posted by the couple on now bears nearly 12,000 signatures.***

In April, the FDA warned that the use of uterine morcellation might allow undetected uterine sarcoma and other cancers to spread outside of the uterus. The agency estimates that 1 in 350 women undergoing fibroid removal have uterine sarcoma cancer cells in their fibroids. Unfortunately, the cancer is almost never discovered until after fibroids have been removed and biopsied. Spread of the disease beyond the uterus will greatly diminish a woman’s chances of long-term survival, according to the FDA.

Since Drs. Noorschasm and Reed began campaigning against power morcellators, court records indicate that a number of morcellator lawsuits have been filed in courts around the country on behalf of women who allegedly experienced the upstaging of uterine cancers due to the devices. Most recently, a case was filed in the U.S. District Court, Northern District of California on May 13, 2014 that claimed the use of a Wolf Power Morcellator promoted the dissemination of uterine cancer cells throughout a woman's peritoneal cavity (Case No. Case5:14-cv-02209-PSG).

Victims of uterine sarcomas or other cancers that were allegedly spread via uterine morcellator may be entitled to file their own power morcellator lawsuit against the manufacturer of the device used in their surgery. To learn more about the risks potentially associated with power morcellators, please visit Bernstein Liebhard LLP’s website. To obtain a free legal review, please call 800-511-5092.

*, Democrat and Chronicle, June 11, 2014
**, CBS, April 25, 2014
***,, July 3, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments
2. When couples disagree on stroke recovery, one partner can suffer
3. Creating friendships between African-American and Caucasian couples can reduce prejudice
4. Couples sleep in sync when the wife is satisfied with their marriage
5. Couples need just 1 conversation to decide not to have children
6. Miami Therapeutic Private Practice Blue Pearl Therapeutic, PA to Begin Seminars on Sex and Intimacy for Couples Including Seminars Catered to the LGBT Community
7. In addiction, meditation is helpful when coupled with drug and cognitive therapies
8. Video Project Shared Via Social Media Gives Hope and Help to Couples Struggling with Infertility
9. Hit a Homerun for the Miracle League of Arizona; Arizona Residents Can Claim a $400 Tax Credit for Couples or $200 for Single Taxpayers
10. Couple Chooses Endless Pool for Their Energy Efficient Home
11. New Technology Increases Chance of Pregnancy for Infertile Couples
Post Your Comments:
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... solution provider of IBM software products, introduced a new company, RightSensor™ LLC, an ... and data communications capability. RightSensor™ provides a fully-managed approach for customers requiring ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Dr. Poneh Ghasri, ... New Today on September 18, 2015. The research, which was conducted at the Dental ... Sabbah and colleagues, show connections between stress during pregnancy and future dental health in ...
(Date:10/13/2015)... ... ... A child without a healthy mouth is much more likely to have an ... has joined with Global Dental Relief (GDR) to help bring dental care ... SmileCareClub will donate one clinic visit to a child in Kenya. , “When SmileCareClub ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, Inc., the ... of Synergy 2015. The annual WennSoft KEY2ACT user conference will take place from ... unite customers, partners, WennSoft team members and sponsors to facilitate the sharing of ...
(Date:10/13/2015)... ... 13, 2015 , ... T-System and Centegra Health System, a ... department visits per year, today announced the successful and rapid deployment of EV™, ... and financial outcomes. , In less than four days, Centegra Hospitals ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Calif. , Oct. 13, 2015  Asterias ... agreement with the UK-based Cell Therapy Catapult to ... AST-VAC2, Asterias, allogeneic dendritic cell immunotherapy. Under the ... scale manufacturing processes for AST-VAC2 to support advanced ... --> --> The ...
(Date:10/12/2015)... -- Use this report to: - Learn ... the medical membrane devices market. - Analyze the present ... medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous ... devices. - Gain information on newly approved products, recalls ... Use this report to: - Learn about the performance, ...
(Date:10/12/2015)... Texas , Oct. 12, 2015  Luminex Corporation (NASDAQ: ... results for the third quarter ended September 30, 2015 on ... is scheduled for release after the close of trading. ... hold a conference call to discuss the operating highlights and ... on November 2, 2015, at 4:30 p.m. Eastern time. ...
Breaking Medicine Technology: